Compare BCTX & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCTX | TSE |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0M | 19.9M |
| IPO Year | N/A | 2014 |
| Metric | BCTX | TSE |
|---|---|---|
| Price | $4.33 | $0.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $40.00 | $1.00 |
| AVG Volume (30 Days) | 858.8K | ★ 1.7M |
| Earning Date | 03-11-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 4.21% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,133,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $380.95 | $4.11 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.10 | $0.43 |
| 52 Week High | $98.20 | $5.99 |
| Indicator | BCTX | TSE |
|---|---|---|
| Relative Strength Index (RSI) | 37.42 | 37.77 |
| Support Level | $4.10 | $0.44 |
| Resistance Level | $4.56 | $0.95 |
| Average True Range (ATR) | 0.71 | 0.09 |
| MACD | -0.25 | -0.00 |
| Stochastic Oscillator | 3.12 | 7.08 |
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.